Adamas Pharmaceuticals, Inc. ADMS
Day range unavailable
52-week range unavailable
- Open
- —
- Prev close
- 0.00
- Mkt cap
- 376.37M
- Vol
- 0
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- —
- High
- —
- Forward P/E
- -22.22
- Beta
- 0.00
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 10, 2021
- 50-d avg
- 7.00
- 200-d avg
- 5.54
- 1y target
- 8.52
MAX chart
Chart tools
Chart is warming up
The all-time price history for ADMS has not been loaded yet. Try again in a moment.
P/E -2.7×
P/S 2.0×
P/B -3.0×
P/FCF -3.0×
EV/EBITDA -4.9×
EV/Sales 2.8×
FCF Yield -33.3%
Gross Margin 97.3%
Operating Margin -59.3%
Net Margin -77.1%
ROE 114.9%
ROIC -49.7%
ROA -47.8%
Revenue 36.3%
Operating Income 52.1%
EPS (diluted) 57.1%
Free Cash Flow 37.2%
Current Ratio 3.2×
Quick Ratio 3.0×
Debt / Equity -2.6×
Net Debt / EBITDA -1.3×
Interest Coverage -3.3×
Dividend Yield 0.0%
Payout Ratio 0.0%
Annual · latest fiscal year ends 2020-12-31